ID1 Promotes Breast Cancer Metastasis by S100A9 Regulation

被引:37
|
作者
Gumireddy, Kiranmai [1 ]
Li, Anping [1 ]
Kossenkov, Andrew V. [1 ]
Cai, Kathy Q. [2 ]
Liu, Qin [1 ]
Yan, Jinchun [3 ]
Xu, Hua [4 ,5 ]
Showe, Louise [1 ]
Zhang, Lin [6 ,7 ]
Huang, Qihong [1 ]
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[2] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA
[3] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Urol, Wuhan 430074, Peoples R China
[6] Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA
[7] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA
基金
中国国家自然科学基金;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; LOOP-HELIX PROTEINS; CELL-GROWTH; TRANSCRIPTIONAL REGULATOR; TUMOR-METASTASIS; GENE-EXPRESSION; ID-1; INVASION; INSIGHTS; IDENTIFICATION;
D O I
10.1158/1541-7786.MCR-14-0049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis is a major factor responsible for mortality in patients with breast cancer. Inhibitor of DNA binding 1 (Id1) has been shown to play an important role in cell differentiation, tumor angiogenesis, cell invasion, and metastasis. Despite the data establishing Id1 as a critical factor for lung metastasis in breast cancer, the pathways and molecular mechanisms of Id1 functions in metastasis remain to be defined. Here, we show that Id1 interacts with TFAP2A to suppress S100A9 expression. We show that expression of Id1 and S100A9 is inversely correlated in both breast cancer cell lines and clinical samples. We also show that the migratory and invasive phenotypes in vitro and metastasis in vivo induced by Id1 expression are rescued by reestablishment of S100A9 expression. S100A9 also suppresses the expression of known metastasis-promoting factor RhoC activated by Id1 expression. Our results suggest that Id1 promotes breast cancer metastasis by the suppression of S100A9 expression. (C) 2014 AACR.
引用
收藏
页码:1334 / 1343
页数:10
相关论文
共 50 条
  • [1] S100A9 Is a Novel Ligand of EMMPRIN That Promotes Melanoma Metastasis
    Hibino, Toshihiko
    Sakaguchi, Masakiyo
    Miyamoto, Shoko
    Yamamoto, Mami
    Motoyama, Akira
    Hosoi, Junichi
    Shimokata, Tadashi
    Ito, Tomonobu
    Tsuboi, Ryoji
    Huh, Nam-ho
    CANCER RESEARCH, 2013, 73 (01) : 172 - 183
  • [2] Diagnostic importance of S100A9 and S100A12 in breast cancer
    Gunaldi, Meral
    Okuturlar, Yildiz
    Gedikbasi, Asuman
    Akarsu, Cevher
    Karabulut, Mehmet
    Kural, Alev
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 76 : 52 - 56
  • [3] Clinical importance of S100A9 and S100A2 in breast cancer
    Gunaldi, M.
    Okuturlar, Y.
    Ustunguler, A.
    Akarsu, C.
    Kural, A.
    CANCER RESEARCH, 2016, 76
  • [4] LINC00852 Promotes Lung Adenocarcinoma Spinal Metastasis by Targeting S100A9
    Liu, Peng
    Wang, Houlei
    Liang, Yun
    Hu, Annan
    Xing, Rong
    Jiang, Libo
    Yi, Lei
    Dong, Jian
    JOURNAL OF CANCER, 2018, 9 (22): : 4139 - 4149
  • [5] S100A8 and S100A9 regulate lung metastasis
    Maru, Yoshiro
    SEIKAGAKU, 2007, 79 (09): : 871 - 874
  • [6] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [7] A novel small molecule antagonist of Id1 inhibits breast cancer metastasis to the lungs.
    Wojnarowicz, P. M.
    Shah, R.
    Benezra, R.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [8] Serum S100A8/S100A9 levels are associated with increased risk of brain metastasis in patients with aggressive breast cancer
    Villodre, Emilly S.
    Hu, Xiaoding
    Song, Juhee
    Gomez, Kristen
    Su, Xiaoping
    Reuben, James
    Ueno, Naoto T.
    Tripathy, Debu
    Krishnamurthy, Savitri
    Debeb, Bisrat
    CANCER RESEARCH, 2023, 83 (05)
  • [9] Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer
    Tsuchiya, T
    Okaji, Y
    Tsuno, NH
    Sakurai, D
    Tsuchiya, N
    Kawai, K
    Yazawa, K
    Asakage, M
    Yamada, J
    Yoneyama, S
    Kitayama, J
    Osada, T
    Watanabe, T
    Tokunaga, K
    Takahashi, K
    Nagawa, H
    CANCER SCIENCE, 2005, 96 (11) : 784 - 790
  • [10] S100A9 is a novel biomarker for poor survival of breast cancer patients
    Noetzel, Erik
    Schutz, Anke
    Bernhagen, Jurgen
    Hartmann, Arndt
    Dahl, Edgar
    Knuchel-Clarke, Ruth
    CANCER RESEARCH, 2010, 70